Inogen Inventory vs Non Current Liabilities Total Analysis
INGN Stock | USD 7.87 0.58 6.86% |
Inogen financial indicator trend analysis is infinitely more than just investigating Inogen Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Inogen Inc is a good investment. Please check the relationship between Inogen Inventory and its Non Current Liabilities Total accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
Inventory vs Non Current Liabilities Total
Inventory vs Non Current Liabilities Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Inogen Inc Inventory account and Non Current Liabilities Total. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Inogen's Inventory and Non Current Liabilities Total is 0.85. Overlapping area represents the amount of variation of Inventory that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of Inogen Inc, assuming nothing else is changed. The correlation between historical values of Inogen's Inventory and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Inventory of Inogen Inc are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Inventory i.e., Inogen's Inventory and Non Current Liabilities Total go up and down completely randomly.
Correlation Coefficient | 0.85 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Inventory
Non Current Liabilities Total
Most indicators from Inogen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Inogen Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. As of the 14th of June 2024, Selling General Administrative is likely to grow to about 79 M, while Tax Provision is likely to drop about 740 K.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 176.5M | 153.5M | 136.5M | 117.0M | Total Revenue | 358.0M | 377.2M | 315.7M | 250.3M |
Inogen fundamental ratios Correlations
Click cells to compare fundamentals
Inogen Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Inogen fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 447.3M | 461.9M | 489.5M | 405.0M | 326.2M | 292.0M | |
Other Current Liab | 12.0M | 14.1M | 23.9M | 19.0M | 60.9M | 63.9M | |
Total Current Liabilities | 50.2M | 56.7M | 61.5M | 65.3M | 72.5M | 41.7M | |
Total Stockholder Equity | 344.6M | 349.6M | 370.2M | 297.4M | 204.8M | 222.6M | |
Property Plant And Equipment Net | 25.3M | 37.1M | 63.8M | 64.9M | 70.7M | 38.5M | |
Current Deferred Revenue | 5.5M | 7.0M | 8.6M | 8.9M | 8.0M | 4.7M | |
Net Debt | (191.3M) | (202.0M) | (208.9M) | (163.7M) | (103.6M) | (108.7M) | |
Retained Earnings | 81.4M | 75.6M | 69.3M | (14.5M) | (116.9M) | (111.1M) | |
Accounts Payable | 30.7M | 33.7M | 25.7M | 34.0M | 27K | 25.7K | |
Cash | 198.0M | 212.0M | 235.5M | 187.0M | 125.5M | 130.8M | |
Non Current Assets Total | 155.1M | 156.2M | 160.3M | 100.4M | 119.1M | 87.1M | |
Non Currrent Assets Other | 4.9M | 2.7M | 3.4M | 2.4M | 3.8M | 2.0M | |
Cash And Short Term Investments | 209.1M | 231.2M | 245.5M | 187.0M | 128.5M | 144.0M | |
Net Receivables | 37.3M | 31.8M | 25.8M | 64.4M | 42.2M | 31.3M | |
Common Stock Shares Outstanding | 22.2M | 22.0M | 22.5M | 22.9M | 23.2M | 22.7M | |
Liabilities And Stockholders Equity | 447.3M | 461.9M | 489.5M | 405.0M | 326.2M | 292.0M | |
Non Current Liabilities Total | 52.5M | 55.5M | 57.8M | 42.3M | 48.9M | 27.6M | |
Inventory | 35.7M | 24.8M | 31.9M | 34.1M | 21.8M | 19.9M | |
Other Current Assets | 10.2M | 17.9M | 26.0M | 19.2M | 14.5M | 8.7M | |
Other Stockholder Equity | 263.3M | 273.5M | 299.5M | 312.1M | 320.5M | 203.3M | |
Total Liab | 102.7M | 112.2M | 119.3M | 107.6M | 121.4M | 69.4M | |
Property Plant And Equipment Gross | 25.3M | 37.1M | 90.6M | 95.1M | 118.5M | 124.4M | |
Total Current Assets | 292.2M | 305.7M | 329.2M | 304.6M | 207.1M | 204.8M | |
Accumulated Other Comprehensive Income | (87K) | 475K | 1.5M | (243K) | 1.2M | 1.3M | |
Short Term Debt | 2.0M | 1.9M | 3.4M | 3.5M | 3.7M | 4.9M | |
Intangible Assets | 77.5M | 68.8M | 60.1M | 177K | 34.6M | 21.3M | |
Other Liab | 47.8M | 47.4M | 34.5M | 22.5M | 25.9M | 20.4M | |
Other Assets | 19.3M | 17.1M | 3.4M | 2.4M | 2.2M | 2.1M | |
Property Plant Equipment | 19.4M | 28.2M | 38.9M | 43.3M | 49.8M | 31.0M | |
Net Tangible Assets | 234.1M | 247.7M | 277.1M | 264.4M | 304.0M | 242.1M | |
Good Will | 33.0M | 33.2M | 33.0M | 32.9M | 10.1M | 16.1M | |
Retained Earnings Total Equity | 81.4M | 75.6M | 69.3M | (14.5M) | (16.7M) | (15.8M) | |
Short Term Investments | 43.7M | 11.1M | 19.3M | 10.0M | 3.0M | 2.8M | |
Deferred Long Term Liab | 9.8M | 232K | 87K | 25K | 22.5K | 21.4K | |
Capital Surpluse | 263.3M | 273.5M | 299.5M | 312.1M | 358.9M | 273.5M | |
Non Current Liabilities Other | 52.5M | 55.5M | 57.8M | 42.3M | 48.6M | 32.2M | |
Accumulated Depreciation | (44.9M) | (45.8M) | (51.7M) | (51.8M) | (46.7M) | (49.0M) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Information and Resources on Investing in Inogen Stock
When determining whether Inogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inogen Inc Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inogen. If investors know Inogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.873 | Earnings Share (4.16) | Revenue Per Share 13.815 | Quarterly Revenue Growth 0.081 | Return On Assets (0.11) |
The market value of Inogen Inc is measured differently than its book value, which is the value of Inogen that is recorded on the company's balance sheet. Investors also form their own opinion of Inogen's value that differs from its market value or its book value, called intrinsic value, which is Inogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inogen's market value can be influenced by many factors that don't directly affect Inogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.